The U.S. Environmental Protection Agency (USEPA) and the International Council of Chemical Associations (ICCA) will co-sponsor a meeting on the public health applications of human biomonitoring. Advances in measurement technology have made widespread application of biomonitoring for health tracking, trends monitoring, and other public health management purposes potentially possible. There are efforts at the Federal and State levels to collect information on human exposure to environmental toxicants and to be able to assess public health outcomes resulting from policy decisions. Because of the widespread interest in collecting biomonitoring information, coupled with the advances in measurement and analytical technologies, the time is ripe for scientists and policy makers to have a conversation about the use of biomonitoring information for public health purposes. The primary purpose of the meeting is to provide a venue to exchange information on the state of the science for using biomonitoring in a public health context, to evaluate the available approaches, and to discuss the issues associated with the public health applications of biomonitoring.
| Author |
Presentation Title |
Duane Alexander,
NICHD |
Childrens Environmental Health: Biomonitoring and the National Childrens Study (PDF) (36 pp, 1.3 MB) |
Tye Arbuckle,
Health Canada |
Maternal-Infant Biomonitoring: The Epidemiological Challenges (PDF) (29 pp, 700 KB) |
John Balbus,
Environmental Defense |
Biomonitoring: A Public Interest and Public Health Perspective (PDF) (32 pp, 1.1 MB) |
Cynthia Bearer,
Case University |
Biomarker for Prenatal Ethanol Exposure: Identifying a Vulnerable Population (PDF) (41 pp, 327 KB) |
Asa Bradman,
University of California at Berkeley |
Reporting Biomonitoring Results to Individuals and Medical and Public Audiences: Challenges and Opportunities (PDF) (37 pp, 2.0 MB) |
Harvey Clewell,
The Hamner Institutes for Health Sciences |
The Application of Probabilistic Reverse Dosimetry for Interpreting Human Biomonitoring Data (PDF) (35 pp, 521 KB) |
Peter Farmer,
University of Leicester |
Biomarkers of Exposure and Effect to Environmental Carcinogens, and Their Applicability to Human Molecular Epidemiological Studies (PDF) (34 pp, 511 KB) |
Jane Gallagher,
U.S. Environmental Protection Agency |
Mechanistic Indicators of Childhood Asthma (MICA)Integrating Environmental, Clinical and Susceptibility Markers to Improve the Impact of Human Air Pollution Studies (PDF) (39 pp, 3.2 MB) |
Sean Hays,
Summit Toxicology |
Interpretation of Human Biomonitoring Data in a Public Health Risk Context Using Biomonitoring Equivalents (PDF) (26 pp, 320 KB) |
Carol Henry,
American Chemistry Council |
International Council of Chemical Associations: A Global Perspective (PDF) (15 pp, 601 KB) |
Beverly Kingsley,
Centers for Disease Control and Prevention |
CDCs Environmental Public Health Tracking Network and Biomonitoring (PDF) (34 pp, 1.0 MB) |
Lisbeth Knudsen,
University of Copenhagen |
Biomonitoring in Europe: Ethics (PDF) (47 pp, 1.7 MB) |
Katarina Magulova,
United Nations Environment Programme |
The POPs Global Monitoring Plan Under the Stockholm Convention (PDF) (26 pp, 96 KB) |
Marsha Morgan,
U.S. Environmental Protection Agency |
Interpretation of Human Biomonitoring Data Using a Forward Dosimetry Approach: Permethrin a Case Study (PDF) (31 pp, 1.4 MB) |
Janet Mostowy,
Bayer Corporation |
Workshop Objectives and Expectations of Outcome (PDF) (5 pp, 39 KB) |
Jay Van Oostdam,
Health Canada |
Human Health Implications of Arctic Environmental Contaminants (PDF) (38 pp, 2.3 MB) |
Jim Quackenboss,
U.S. Environmental Protection Agency |
Opportunities for Linking Biomonitoring Data to Risk Assessment and Public Health in the National Childrens Study (PDF) (33 pp, 705 KB) |
Stephen Rappaport,
University of California at Berkeley |
Using Biomarkers to Characterize Human Benzene Metabolism (PDF) (23 pp, 1.5 MB) |
Pat Rizzuto,
BNA, Inc. |
Challenges in Communicating: One Reporters Perspective (PDF) (12 pp, 52 KB)) |
Madeleine Scammell,
Boston University School of Public Health |
The Boston Consensus Conference on Biomonitoring: Process, Findings and Recommendations (PDF) (27 pp, 738 KB) |
Greet Schoeters,
VITO ( Flemish Institute for Technological Research) |
The Flemish Environmental Human Biomonitoring Program: 20022006 (PDF) (26 pp, 345 KB) |
Ovnair Sepai,
UK Health Protection Agency |
Human Biomonitoring Activities and the Vision for Europe (PDF) (30 pp, 1.8 MB) |
Linda Sheldon,
U.S. Environmental Protection Agency |
Applications of Biomonitoring in Environmental Decision Making (PDF) (29 pp, 238 KB) |
Fumiaki Shono,
Japan Chemical Industry Association |
Challenge to Improving the Precision of Risk Evaluation Systems for Humans (PDF) (19 pp, 315 KB) |
Brenda Weis,
National Institute of Environmental Health Science |
Exposure Biology Program (PDF) (10 pp, 238 KB) |
Robert Zachariasiewicz,
U.S. Environmental Protection Agency |
Communication of Biomonitoring Information (PDF) (11 pp, 124 KB) |
